Page last updated: 2024-09-03

n-acetylneuraminoyllactose and Carcinoma, Pancreatic Ductal

n-acetylneuraminoyllactose has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Higashi, K; Nagahori, H; Saito, K; Yamada, K	1

Other Studies

1 other study(ies) available for n-acetylneuraminoyllactose and Carcinoma, Pancreatic Ductal

Article	Year
Circulating natural antibodies against 3'-sialyllactose complement the diagnostic performance of CA19-9 for the early detection of pancreatic ductal adenocarcinoma. Cancer biomarkers : section A of Disease markers, 2020, Volume: 27, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antibodies; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoma, Pancreatic Ductal; Early Detection of Cancer; Female; Humans; Male; Middle Aged; Oligosaccharides; Pancreas; Prognosis	2020

Article

Year

Circulating natural antibodies against 3'-sialyllactose complement the diagnostic performance of CA19-9 for the early detection of pancreatic ductal adenocarcinoma.

Cancer biomarkers : section A of Disease markers, 2020, Volume: 27, Issue:1

Topics: Adenocarcinoma; Adult; Aged; Antibodies; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoma, Pancreatic Ductal; Early Detection of Cancer; Female; Humans; Male; Middle Aged; Oligosaccharides; Pancreas; Prognosis

2020